Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5AOL

Structure of the p53 cancer mutant Y220C with bound 3-bromo-5-(trifluoromethyl)benzene-1,2-diamine

Summary for 5AOL
Entry DOI10.2210/pdb5aol/pdb
Related5AOI 5AOJ 5AOK 5AOM
DescriptorCELLULAR TUMOR ANTIGEN P53, 3-BROMO-5-(TRIFLUOROMETHYL)BENZENE-1,2-DIAMINE, ZINC ION, ... (4 entities in total)
Functional Keywordscell cycle, p53, cancer, tumor suppression, dna binding, cancer therapy, small-molecule stabilizers, molecular chaperone
Biological sourceHOMO SAPIENS (HUMAN)
Total number of polymer chains2
Total formula weight49447.48
Authors
Joerger, A.C.,Harbrecht, H. (deposition date: 2015-09-10, release date: 2015-12-16, Last modification date: 2024-01-10)
Primary citationJoerger, A.C.,Bauer, M.R.,Wilcken, R.,Baud, M.G.J.,Harbrecht, H.,Exner, T.E.,Boeckler, F.M.,Spencer, J.,Fersht, A.R.
Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant P53.
Structure, 23:2246-, 2015
Cited by
PubMed Abstract: The destabilizing p53 cancer mutation Y220C creates an extended crevice on the surface of the protein that can be targeted by small-molecule stabilizers. Here, we identify different classes of small molecules that bind to this crevice and determine their binding modes by X-ray crystallography. These structures reveal two major conformational states of the pocket and a cryptic, transiently open hydrophobic subpocket that is modulated by Cys220. In one instance, specifically targeting this transient protein state by a pyrrole moiety resulted in a 40-fold increase in binding affinity. Molecular dynamics simulations showed that both open and closed states of this subsite were populated at comparable frequencies along the trajectories. Our data extend the framework for the design of high-affinity Y220C mutant binders for use in personalized anticancer therapy and, more generally, highlight the importance of implementing protein dynamics and hydration patterns in the drug-discovery process.
PubMed: 26636255
DOI: 10.1016/J.STR.2015.10.016
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.5 Å)
Structure validation

237992

数据于2025-06-25公开中

PDB statisticsPDBj update infoContact PDBjnumon